Vericel (VCEL) EBITDA Margin (2011 - 2026)

Vericel's (VCEL) quarterly EBITDA Margin came in at 11.79% in Q1 2026, up 1254.0% year-on-year from 0.87% in Q1 2025, and down 148.85% quarter-over-quarter from 24.12% in Q4 2025.

Vericel (VCEL) EBITDA Margin (2011 - 2026) Analysis & Trends

Vericel has disclosed EBITDA Margin across 16 years of filings, most recently posting 11.79% for Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 11.79%, up 1254.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.4% (up 658.0% YoY), and the FY2025 annual result was 4.0%, up 209.0% from the prior year.
  • EBITDA Margin came in at 11.79% for Q1 2026 at Vericel, down from 24.12% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 24.52% in Q4 2024 to a low of 24.52% in Q2 2022.
  • The 5-year median for EBITDA Margin is 11.09% (2023), against an average of 5.13%.
  • Across the five-year window, EBITDA Margin tumbled 1508 bps in 2022 and jumped 1254 bps in 2026, its largest moves.
  • Vericel's EBITDA Margin stood at 11.55% in 2022, then soared by 70 bps to 19.59% in 2023, then advanced by 25 bps to 24.52% in 2024, then retreated by 2 bps to 24.12% in 2025, then slumped by 149 bps to 11.79% in 2026.
  • The last three EBITDA Margin figures came in at 11.79% (Q1 2026), 24.12% (Q4 2025), and 5.11% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn -11.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.79%
Dec 31, 2025 24.12%
Sep 30, 2025 5.11%
Jun 30, 2025 -3.21%
Mar 31, 2025 -24.32%
Dec 31, 2024 24.52%
Sep 30, 2024 -4.26%
Jun 30, 2024 -11.45%
Mar 31, 2024 -10.66%
Dec 31, 2023 19.59%
Sep 30, 2023 -11.09%
Jun 30, 2023 -12.98%
Mar 31, 2023 -19.94%
Dec 31, 2022 11.55%
Sep 30, 2022 -17.61%
Jun 30, 2022 -24.52%
Mar 31, 2022 -20.29%
Dec 31, 2021 8.70%
Sep 30, 2021 -14.38%
Jun 30, 2021 -9.44%